The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) for the delivery of primer kits and probe kits. The $154,671.98 contract has a completion date of October 2, 2020 and is associated with the Coronavirus COVID-19 national interest action. IDT, a manufacturer of nucleic acid products, has previously supplied the federal government with a range of goods and services including...
The Centers for Disease Control and Prevention (CDC) awarded a $249,540 purchase order to Integrated DNA Technologies, Inc. (IDT) for pandemic rapid primers. IDT will provide primer products to the CDC under this firm fixed-price contract, which runs from September 2023 through September 2024. The place of performance for the contract is IDT's facility in Coralville, Iowa. As the nation's leading public health agency, the CDC works to protect public health and safety through the control and...
This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT) for the delivery of primers and probes. The contract, valued at $90,225.60, has a period of performance ending on March 13, 2020. IDT is a leading provider of specialized nucleic acid products and services to various federal agencies, including the CDC, supporting biomedical research, pandemic response, and public health initiatives. This award is...
Integrated DNA Technologies, Inc., doing business as IDT, has been awarded a $13,669.50 purchase order contract by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania. Under the terms of the contract, IDT PRIMETIME PROBES, IDT will provide probe products to the CDC to support its disease prevention and health promotion efforts. Performance will take place in Coralville, Iowa over a period of approximately one month, concluding on October 2, 2023. The contract has a...
Integrated DNA Technologies, Inc. (IDT) has been awarded a firm fixed price purchase order totaling $670,359.20 by the Centers for Disease Control and Prevention (CDC) to provide custom reagents for SARS-CoV-2 genomic sequencing through September 30, 2022. The products will support the CDC's detection and monitoring of COVID-19 variants. No set-aside designation was applied to this procurement. IDT will deliver the reagents from its location in Atlanta, Georgia under the base indefinite...
This is a $115,346.90 firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT), a manufacturer of nucleic acid products for the life sciences industry. The contract supports COVID-19 response efforts and is not set aside. IDT has a Federal Supply Schedule contract with the Department of Veterans Affairs to provide oligonucleotides, probes, and custom DNA/RNA synthesized...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT), a manufacturer of nucleic acid products, for the supply of PROBEKITS. The $137,179.84 firm fixed price purchase order does not have a set-aside designation. IDT is a major supplier of oligonucleotides, probes, reagents, and other products to federal agencies like the National Institutes of Health, Department of Defense,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Purchase Order to Integrated DNA Technologies, Inc. (IDT), a manufacturer of nucleic acid products, on June 2, 2020. The $154,671.98 contract supports COVID-19 response efforts and has a completion date of August 31, 2020. IDT, a for-profit organization, has an active Federal Supply Schedule contract with the Department of Veterans Affairs to provide oligonucleotides, probes, and...
This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT) for the provision of SPIKE PRIMER SETS AND AMPLICON PANEL, with a ceiling value of $187,940.00 and a period of performance ending on September 29, 2024. The award was made on a sole-source basis, as IDT is the only manufacturer of the proprietary "XGEN" technology validated by the CDC for whole genome sequencing of SARS-CoV-2 to support...
The Centers for Disease Control and Prevention (CDC) awarded a $249,445 firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) to provide oligonucleotides and gene production in support of the development of COVID-19 vaccine candidates. The award does not have a set-aside designation. IDT is a major provider of specialized nucleic acid products and services to federal agencies, including the NIH, CDC, DoD, and USDA, through prime contracts and subcontracts. The company...